Program Manager, Type 1 Diabetes - Markets

Overview

The Clinton Health Access Initiative, Inc. (CHAI) is a global health organization committed to our mission of saving lives and reducing the burden of disease in low-and middle-income countries. We work at the invitation of governments to support them and the private sector to create and sustain high-quality health systems.

 

CHAI was founded in 2002 in response to the HIV/AIDS epidemic, with the goal of dramatically reducing the price of life-saving drugs and increasing access to these medicines in the countries with the highest burden of the disease. Over the following two decades, CHAI has expanded its focus. Today, along with HIV, we work in conjunction with our partners to prevent and treat infectious diseases such as COVID-19, malaria, tuberculosis, and hepatitis. Our work has also expanded into cancer, diabetes, hypertension, and other non-communicable diseases, and we work to accelerate the rollout of lifesaving vaccines, reduce maternal and child mortality, combat chronic malnutrition, and increase access to assistive technology. We are investing in horizontal approaches to strengthen health systems through programs in human resources for health, digital health, and health financing. With each new and innovative program, our strategy is grounded in maximizing sustainable impact at scale, ensuring that governments lead the solutions, that programs are designed to scale nationally, and learnings are shared globally.

 

At CHAI, our people are our greatest asset, and none of this work would be possible without their talent, time, dedication and passion for our mission and values. We are a highly diverse team of enthusiastic individuals across 40 countries with a broad range of skill sets and life experiences. CHAI is deeply grounded in the countries we work in, with the majority of our staff based in program countries. Learn more about our exciting work: http://www.clintonhealthaccess.org

 

CHAI is an Equal Opportunity Employer, and is committed to providing an environment of fairness, and mutual respect where all applicants have access to equal employment opportunities. CHAI values diversity and inclusion, and recognizes that our mission is best advanced by the leadership and contributions of people with diverse experience, backgrounds, and culture. For this role especially, we strongly encourage individuals from low- and middle-income countries (LMICs) and those with lived experience of type 1 diabetes to apply.

 

 

Overview of CHAI’s work in Type 1 Diabetes and other Non-Communicable Diseases

 

Across the globe, more than 9.4 million people are living with type 1 diabetes (T1D) (Breakthrough T1D, 2024). This burden is growing – by 2040, there are expected to be almost 17.5 million people living with T1D, among whom 4.2 million will be children and adolescents under 25 (Breakthrough T1D, 2024). In LMICs, poor access to T1D care means many people die before they are diagnosed and receive treatment. For those receiving treatment, there are significant gaps in access to equitable standards of care. Lifelong costs associated with managing T1D are also prohibitive and, in many cases, even catastrophic for people with T1D and their families.

 

The resulting disparities in health outcomes for people living with T1D around the world are enormous, with life expectancy at just 24 years in low-income countries and 37 years in lower-middle-income countries (Breakthrough T1D, 2024). In contrast, in high-income countries (HICs), the life expectancy of people living with T1D is comparable to that of those without. Hence, while care for T1D is complex and a daily challenge for people living with T1D, especially children and adolescents, the high life expectancy in high-income countries is a testament that we have the tools available to enable people living with T1D to live long and high-quality lives.

 

Over the last year, CHAI has been supporting the establishment of a T1D Alliance across several major organizations that are investing in projects to improve access to T1D care, with the aim of coordinating their investments behind a shared strategy of government- and community-defined priorities, to improve impact, sustainability and value-for-money of their investments. Whilst the initial phase of this initiative focused on developing a common strategy with input from a wide range of country- and global-level stakeholders, the Alliance is now moving towards operationalization of this vision.

 

As of October, an interim Secretariat will be operational, with CHAI likely to be contracted to fulfill this interim Secretariat role for the Alliance during a Start-up Phase (October 2025-December 2026). The interim Secretariat will guide overall strategy implementation across 3 areas of work:

Invest in countries & communities: Initia